NCT04788927View on ClinicalTrials.gov

Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

Not yet recruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

September 30, 2027

Conditions

ParagangliomaPheochromocytomaGenetic Predisposition to DiseasePathologySomatic MutationHead and Neck CancerNeuroendocrine Tumors

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

DK-2100

National University Hospital, Department of Medical Endocrinology, Copenhagen

All Listed Sponsors

lead

Rigshospitalet, Denmark

OTHER

NCT04788927 - Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study | Biotech Hunter | Biotech Hunter